Investigación
Educación
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Obstetrics and Gynecology
Zhenxiao Lu has not added Biography.
If you are Zhenxiao Lu and would like to personalize this page please email our Author Liaison for assistance.
FOXO1A differentially regulates genes of decidualization.
Endocrinology Aug, 2006 | Pubmed ID: 16690806
Progestins activate the AKT pathway in leiomyoma cells and promote survival.
The Journal of clinical endocrinology and metabolism May, 2009 | Pubmed ID: 19240153
Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.
Hormones & cancer Jun, 2011 | Pubmed ID: 21760855
Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.
The Journal of clinical endocrinology and metabolism Jan, 2012 | Pubmed ID: 22072736
Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
PloS one , 2012 | Pubmed ID: 22911820
Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.
The Journal of clinical endocrinology and metabolism Dec, 2013 | Pubmed ID: 24064688
Inactivation of AKT induces cellular senescence in uterine leiomyoma.
Endocrinology Apr, 2014 | Pubmed ID: 24476133
Northwestern University
Alina R. Murphy*,1,
Teerawat Wiwatpanit*,2,
Zhenxiao Lu1,
Batzaya Davaadelger1,
J. Julie Kim1
1Department of Obstetrics and Gynecology, Northwestern University,
2National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA)
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados